A. S. Ng

AKTIP loss is enriched in ERα-positive breast cancer for tumorigenesis and confers endocrine resistance

Yiling Lu, Wei Zhao, L. W. Cheung, 2022, Cell reports.

Cancer-associated mutations in the p85α N-terminal SH2 domain activate a spectrum of receptor tyrosine kinases

S. Arold, P. Ng, Yuan Zhou, 2021, Proceedings of the National Academy of Sciences.

Strategic combination therapies for ovarian cancer.

A. Cheung, Lydia W. T. Cheung, Karen K. L. Chan, 2020, Current cancer drug targets.

PRMT1 is a critical dependency in clear cell renal cell carcinoma through its role in post-transcriptional regulation of DNA damage response genes

B. Raught, C. Arrowsmith, P. Prinos, 2023, bioRxiv.